Skip to content

The Erlangen Fitness and Prevention Study (EFOPS).

Effects of Exercise on Fracture Risk, Bone Mineral Density and Falls in Postmenopausal Women. The Long-term Erlangen Fitness and Prevention Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01177761
Acronym
EFOPS
Enrollment
50
Registered
2010-08-09
Start date
1998-10-31
Completion date
2023-11-30
Last updated
2023-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Postmenopause, Osteopenia, Osteoporosis

Keywords

Osteoporosis, exercise, fractures, Bone Mineral Density, CHD-risk

Brief summary

The study determines the long-term effect of exercise on osteoporotic fracture risk. Since actually no controlled supervised exercise study exceeds the time frame of 4 years, knowledge concerning the long-term effect of exercise on fractures and fracture-risk factors is scarce. Within the Erlanger Fitness and Osteoporosis Study (EFOPS, an ongoing controlled exercise study with currently 16 years of supervised exercise with 45-50 osteopenic, early-postmenopausal women in exercise and sedentary control group each, the investigators therefore focus on overall-fractures, Bone Mineral Density and falls.

Interventions

PROCEDUREphysical exercise

Two sessions/week, 50 weeks/year over 12 years of high intensity exercise training

Sponsors

Behinderten- und Versehrten-Sportverband Bayern e.V.
CollaboratorOTHER
Netzwerk Knochengesundheit e.V.
CollaboratorUNKNOWN
University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
48 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* participants of the EFOPS-study, * 12 years of exercise training according to the EFOPS-protocol (exercise).

Exclusion criteria

* medication and diseases affecting bone metabolism, * inflammable diseases, * cardiovascular diseases, * start of relevant physical exercise programs beside the EFOPS protocol.

Design outcomes

Primary

MeasureTime frameDescription
overall-fractures (low-trauma)16 year follow-upAs assessed by questionnaire and structured interview
Bone Mineral Density at Lumbar Spine and Proximal Femur16 year follow-upAs assessed by Dual-Energy X-ray Absorptiometry (DEXA)

Secondary

MeasureTime frameDescription
10-year coronary heart disease (CHD) risk16 year follow-upAs assessed by Framingham Risk Factor Calculator according to Wilson.
Metabolic Syndrome Z-Score16 year follow-upMetabolic Syndrome Z-Score Index according to Johnson

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026